TY - JOUR
T1 - Absolute immunoquantification of the expression of ABC transporters P-glycoprotein, breast cancer resistance protein and multidrug resistance-associated protein 2 in human liver and duodenum
AU - Tucker, Theodora G. H. A.
AU - Milne, Alison M.
AU - Fournel-Gigleux, Sylvie
AU - Fenner, Katherine S.
AU - Coughtrie, Michael W. H.
N1 - Copyright © 2011 Elsevier Inc. All rights reserved.
PY - 2012
Y1 - 2012
N2 - The ATP-binding cassette (ABC) transporters breast cancer resistance protein (BCRP), multidrug resistance-associated protein 2 (MRP2), and P-glycoprotein (Pgp) are important in the distribution and elimination of many drugs and endogenous metabolites. Due to their membrane location and hydrophobicity it is difficult to generate purified protein standards to quantify these transporters in human tissues. The present study generated transporter proteins fused with the S-peptide of ribonuclease for use as standards in immunoquantification in human liver and small intestine. Quantification of the S.tag (TM), a 15 amino acid peptide, is based on the formation of a functional ribonuclease activity upon its high affinity reconstitution with ribonuclease S-protein. S-tagged transporters were used as full-length protein standards in the immunoquantification of endogenous BCRP, MRP2, and Pgp levels in 14 duodenum and 13 liver human tissue samples. Expression levels in the duodenum were 305 +/- 248 (BCRP), 66 +/- 70 (MRP2), and 275 +/- 205 (Pgp) fmoles per cm(2). Hepatic levels were 2.6 +/- 0.9 (BCRP), 19.8 +/- 10.5 (MRP2), and 26.1 +/- 10.1 (total Pgp) pmoles per g of liver. The mean hepatic scaling factor was 35.8 mg crude membrane per g of liver, and the mean duodenal scaling factor was 1.3 mg crude membrane per cm(2) mucosal lining. Interindividual variability was greater in duodenal samples than liver samples. It is hoped that this innovative method of quantifying these transporters (and other membrane proteins) will improve in vivo-in vitro extrapolation and in silica prediction of drug absorption and elimination, thus supporting drug development. (C) 2011 Elsevier Inc. All rights reserved.
AB - The ATP-binding cassette (ABC) transporters breast cancer resistance protein (BCRP), multidrug resistance-associated protein 2 (MRP2), and P-glycoprotein (Pgp) are important in the distribution and elimination of many drugs and endogenous metabolites. Due to their membrane location and hydrophobicity it is difficult to generate purified protein standards to quantify these transporters in human tissues. The present study generated transporter proteins fused with the S-peptide of ribonuclease for use as standards in immunoquantification in human liver and small intestine. Quantification of the S.tag (TM), a 15 amino acid peptide, is based on the formation of a functional ribonuclease activity upon its high affinity reconstitution with ribonuclease S-protein. S-tagged transporters were used as full-length protein standards in the immunoquantification of endogenous BCRP, MRP2, and Pgp levels in 14 duodenum and 13 liver human tissue samples. Expression levels in the duodenum were 305 +/- 248 (BCRP), 66 +/- 70 (MRP2), and 275 +/- 205 (Pgp) fmoles per cm(2). Hepatic levels were 2.6 +/- 0.9 (BCRP), 19.8 +/- 10.5 (MRP2), and 26.1 +/- 10.1 (total Pgp) pmoles per g of liver. The mean hepatic scaling factor was 35.8 mg crude membrane per g of liver, and the mean duodenal scaling factor was 1.3 mg crude membrane per cm(2) mucosal lining. Interindividual variability was greater in duodenal samples than liver samples. It is hoped that this innovative method of quantifying these transporters (and other membrane proteins) will improve in vivo-in vitro extrapolation and in silica prediction of drug absorption and elimination, thus supporting drug development. (C) 2011 Elsevier Inc. All rights reserved.
KW - Drug transporters
KW - Immunoquantification
KW - BCRP
KW - MRP2
KW - P-glycoprotein
KW - Tandem mass spectrometry
KW - Export pump
KW - Liquid chromatography
KW - Human intestine
KW - Caco-2 cells
KW - Quantification
KW - Gene
KW - Sulfotransferase
U2 - 10.1016/j.bcp.2011.10.017
DO - 10.1016/j.bcp.2011.10.017
M3 - Article
C2 - 22062654
SN - 0006-2952
VL - 83
SP - 279
EP - 285
JO - Biochemical Pharmacology
JF - Biochemical Pharmacology
IS - 2
ER -